Military Exoskeleton - Global Market Trajectory & Analytics

Global Military Exoskeleton Market to Reach $3.3 Billion by 2027

Amid the COVID-19 crisis, the global market for Military Exoskeleton estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$3.3 Billion by 2027, growing at a CAGR of 13.7% over the period 2020-2027. Full-Body Military Exoskeleton, one of the segments analyzed in the report, is projected to record 11.4% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Partial-Body Military Exoskeleton segment is readjusted to a revised 15% CAGR for the next 7-year period.

The U. S. Market is Estimated at $396.3 Million, While China is Forecast to Grow at 13.3% CAGR

The Military Exoskeleton market in the U. S. is estimated at US$396.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$580 Million by the year 2027 trailing a CAGR of 13.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.8% and 11.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.3% CAGR. We bring years of research experience to this 9th edition of our report. The 108-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

• 20 Knots Plus Ltd.
• Bionic Power Inc.
• General Atomics
• Lockheed Martin Corporation
• Raytheon Company
• Revision Military Ltd.
• Safran
• SpringActive
• SRI International